4//SEC Filing
Smith Mark Alan 4
Accession 0001415889-17-001520
CIK 0001411685other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:32 PM ET
Size
5.5 KB
Accession
0001415889-17-001520
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2017-09-19+100,000→ 100,000 totalExercise: $1.56Exp: 2027-09-19→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001677452
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 4:32 PM ET
- Size
- 5.5 KB